EFFECTS OF ADDING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS TO STANDARD CARE IN PATIENTS WITH TYPE 2 DIABETES

被引：0
|
作者：
Sharma, A. [1 ,2 ]
Kamran, H. [1 ]
Goel, S. [3 ]
Mukherjee, D. [4 ]
机构：
[1] Suny Downstate Med Ctr, Div Cardiovasc Med, New York, NY USA
[2] Inst Cardiovasc Res & Technol, Brooklyn, NY USA
[3] Maimonides Hosp, Dept Cardiol, Brooklyn, NY 11219 USA
[4] Texas Tech Univ, Div Cardiol, El Paso, TX USA
来源：
CARDIOLOGY | 2017年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
079
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [41] RE: Gout and sodium-glucose cotransporter-2 inhibitors
    Lund, Lars Christian
    Hojlund, Mikkel
    Henriksen, Daniel Pilsgaard
    Hallas, Jesper
    Kristensen, Kasper Bruun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 114 - 115
  • [42] Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes
    Dawwas, Ghadeer K.
    Smith, Steven M.
    Park, Haesuk
    DIABETES OBESITY & METABOLISM, 2019, 21 (01): : 28 - 36
  • [43] Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes
    Zhuo, Min
    Hawley, Chelsea E.
    Paik, Julie M.
    Bessette, Lily G.
    Wexler, Deborah J.
    Kim, Dae H.
    Tong, Angela Y.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    JAMA NETWORK OPEN, 2021, 4 (10)
  • [44] Sodium-glucose cotransporter-2 inhibitors and risk for genitourinary infections in older adults with type 2 diabetes
    Varshney, Navya
    Billups, Sarah J.
    Saseen, Joseph J.
    Fixen, Cy W.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2021, 12
  • [45] The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus
    Dong, Meiyuan
    Chen, Huiling
    Wen, Song
    Yuan, Yue
    Yang, Liling
    Xu, Dongxiang
    Zhou, Ligang
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 437 - 445
  • [46] Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review
    Shakour, Neda
    Karami, Shima
    Iranshahi, Mehrdad
    Butler, Alexandra E.
    Sahebkar, Amirhossein
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (01)
  • [47] The anti-hypertensive effects of sodium-glucose cotransporter-2 inhibitors
    Kugathasan, Luxcia
    Dubrofsky, Lisa
    Advani, Andrew
    Cherney, David Z. I.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (01) : 15 - 34
  • [48] Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review
    Figueiredo, Izabela Rodrigues
    Paes Rose, Sara Cardoso
    Freire, Nathalia Bandeira
    Patrocinio, Marina Stabile
    Pierdona, Natalia
    Bittencourt, Roberto Jose
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (02): : 246 - 252
  • [49] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure in Patients With Type 2 Diabetes Mellitus: A Systematic Review
    Abdelhady, Hala A.
    Abakar, Adoum Oumar
    Gangavarapu, Ravindra Reddy
    Mahmud, Sayed A.
    Manandhar, Anura
    Sabir, Ghadeer
    Malasevskaia, Iana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [50] Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms
    Kashihara, Naoki
    Kidokoro, Kengo
    Kanda, Eiichiro
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (01): : 112 - 118
12345